As families in Europe clamor for gene therapy, Novartis creates a lottery

As families in Europe clamor for gene therapy, Novartis creates a lottery

STAT Plus: As families in Europe clamor for its pricey gene therapy, Novartis creates a lottery

By ED SILVERMAN

NOVARTIS VIA AP

The move drew criticism from patient groups over concerns the lottery system would unfairly forsake babies who are at risk from dying from the rare disease.

READ MORE